Company profile: InnAVasc
1.1 - Company Overview
Company description
- Provider of medical devices for vascular access in hemodialysis, focusing on immediate access, home hemodialysis, and dialysis needle protection; offering the InnAVasc Graft with protective backplates and self-sealing materials to prevent needle injuries and bleeding complications.
Products and services
- InnAVasc Graft: engineers hemodialysis vascular access incorporating protective backplates and self-sealing materials to prevent needle injuries and bleeding complications during hemodialysis procedures
- Hemodialysis-specific
- Vascular Access Product Development: architects and develops products for vascular access for hemodialysis, prioritizing immediate access and compatibility with home hemodialysis and dialysis needle protection
- Vascular-access-focused
- Home Hemodialysis Access Products: creates hemodialysis vascular access products intended for home hemodialysis use, supporting immediate access and dialysis needle protection during at-home therapy
- Home-hemodialysis-compatible
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InnAVasc
Acron Genomics
HQ: United Kingdom
Website
- Description: Provider of novel biotechnology platform development and commercialization in the life sciences, and of the introduction and development of promising new pharmaceutical compounds. U.S. publicly traded (OTC Markets/AGNM).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acron Genomics company profile →
Cardiovascular Systems
HQ: United States
Website
- Description: Provider of medical devices for treating peripheral and coronary vascular disease, focusing on plaque removal via orbital atherectomy systems (Diamondback 360 Peripheral and Coronary OAS, Stealth 360), as well as guide wires (ViperWire Advance, Shepherd) and support catheters (ViperCross), helping physicians address difficult disease states, including calcium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiovascular Systems company profile →
EKOS
HQ: United States
Website
- Description: Provider of ultrasound-accelerated thrombolysis systems for the treatment of vascular thrombosis. Its EKOS EkoSonic Endovascular System, introduced in 2005, is used by interventional radiologists, cardiologists, and vascular surgeons at leading institutions worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EKOS company profile →
Armgo Pharma
HQ: United States
Website
- Description: Provider of small molecule therapeutics that repair leaky Ryanodine Receptor (RyR) calcium channels for cardiac, skeletal muscular, and neurological disorders. Offers Rycals, including ARM210 (S48168), in clinical development for RYR1-Related Myopathy (RYR1-RM) and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Armgo Pharma company profile →
Infraredx
HQ: United States
Website
- Description: Provider of catheter-based coronary imaging devices utilizing near-infrared spectroscopy (NIRS) to identify and characterize vulnerable plaque, alongside CME-accredited webinar and educational sessions on polyvascular disease management, intravascular coronary imaging, coronary physiology, patient risk assessment, and imaging-guided interventions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infraredx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InnAVasc
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InnAVasc
2.2 - Growth funds investing in similar companies to InnAVasc
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InnAVasc
4.2 - Public trading comparable groups for InnAVasc
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →